-
公开(公告)号:PL2981308T3
公开(公告)日:2020-08-24
申请号:PL14779243
申请日:2014-03-31
Applicant: CYTOSORBENTS CORP
Inventor: GOLOBISH THOMAS D , CAPPONI VINCENT J , CLAY DAVID R
-
公开(公告)号:MX342421B
公开(公告)日:2016-09-28
申请号:MX2012011305
申请日:2011-04-01
Applicant: CYTOSORBENTS CORP *
Inventor: CHAN PHILLIP P , YOUNG WEI-TAI , CAPPONI VINCENT J , GOLOBISH THOMAS D , BARTLETT ROBERT H , HUMAYRA BEGUM ALI
Abstract: La presente invención es concerniente con métodos de tratamiento de inflamación sistémica, regional o local de un paciente que sufre o está en riesgo de inflamación que comprende la administración de una dosis terapéuticamente efectiva de un sorbente que absorbe un mediador inflamatorio en dicho paciente. En algunas modalidades preferidas, el sorbente es un polímero orgánico biocompartible.
-
公开(公告)号:CA2908202A1
公开(公告)日:2014-10-09
申请号:CA2908202
申请日:2014-03-31
Applicant: CYTOSORBENTS CORP
Inventor: GOLOBISH THOMAS D , CAPPONI VINCENT J , CLAY DAVID R
Abstract: The invention concerns methods of treating blood, blood product, or physiologic fluid to provide at least one of (i) increasing shelf life of the blood, blood product or physiologic fluid, (ii) maintaining freshness of new blood, blood product or physiologic fluid, and (iii) removing undesirable molecules from the blood, blood product or physiologic fluid; said method comprising contacting said blood, blood product or physiologic fluid with a sorbent, said sorbent being primarily in a plurality of solid forms and comprising a cross-linked polymeric material having a plurality of at least one of (1) zwitterionic moieties and (2) oligo(ethylene glycol) moieties attached to the surface of said cross-linked polymeric material.
-
公开(公告)号:CA2877536A1
公开(公告)日:2014-01-03
申请号:CA2877536
申请日:2013-06-28
Applicant: CYTOSORBENTS CORP
Inventor: CHAN PHILLIP P , CAPPONI VINCENT J , GOLOBISH THOMAS D , ALI HUMAYRA BEGUM
Abstract: Provided herein are materials and methods of reducing contamination in a biological substance or treating contamination in a subject by one or more toxins comprising contacting the biological substance with an effective amount of a sorbent capable of sorbing the toxin, wherein the sorbent comprises a plurality of pores ranging from 50Å to 40,000Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and sorbing the toxin. Also provided are kits to reduce contamination by one or more toxins in a biological substance comprising a sorbent capable of sorbing a toxin, wherein the sorbent comprises a plurality of pores ranging from 50Å to 40,000Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and a vessel to store said sorbent when not in use together with packaging for same.
-
公开(公告)号:AU2012204277A1
公开(公告)日:2013-07-18
申请号:AU2012204277
申请日:2012-01-06
Applicant: CYTOSORBENTS CORP
Inventor: CHAN PHILLIP P , CAPPONI VINCENT J , GOLOBISH THOMAS D , ALI HUMAYRA BEGUM
IPC: B32B5/16
Abstract: The invention concerns polymer systems comprising at least one polymer with a plurality of pores where the polymer is initially functionalized on substantially all surfaces followed by a stepwise surface specific functionalization such that a different functional group resides on the external or internal pore surface of the bead. The invention also concerns use of such polymer systems in blood, blood product, or physiologic fluid purification.
-
公开(公告)号:CA2844688A1
公开(公告)日:2013-02-21
申请号:CA2844688
申请日:2012-08-10
Applicant: CYTOSORBENTS CORP
Inventor: CHAN PHILLIP P , CAPPONI VINCENT J , GOLOBISH THOMAS D , ALI HUMAYRA BEGUM
Abstract: The invention concerns methods of treating stored blood and blood products maximizing shelf life and/or minimizing transfusion related complications such as non¬ hemolytic transfusion reactions such as fever, transfusion-related acute lung injury (TRALI), transfusion associated dyspnea (TAD), and allergic reactions by removing undesirable molecules in the blood and blood products milieu through use of a sorbent.
-
公开(公告)号:PL2866854T3
公开(公告)日:2021-01-11
申请号:PL13810619
申请日:2013-06-28
Applicant: CYTOSORBENTS CORP
Inventor: CHAN PHILLIP P , CAPPONI VINCENT J , GOLOBISH THOMAS D , ALI HUMAYRA BEGUM
-
公开(公告)号:CA2877536C
公开(公告)日:2020-12-29
申请号:CA2877536
申请日:2013-06-28
Applicant: CYTOSORBENTS CORP
Inventor: CHAN PHILLIP P , CAPPONI VINCENT J , GOLOBISH THOMAS D , ALI HUMAYRA BEGUM
Abstract: Provided herein are materials and methods of reducing contamination in a biological substance or treating contamination in a subject by one or more toxins comprising contacting the biological substance with an effective amount of a sorbent capable of sorbing the toxin, wherein the sorbent comprises a plurality of pores ranging from 50Å to 40,000Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and sorbing the toxin. Also provided are kits to reduce contamination by one or more toxins in a biological substance comprising a sorbent capable of sorbing a toxin, wherein the sorbent comprises a plurality of pores ranging from 50Å to 40,000Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and a vessel to store said sorbent when not in use together with packaging for same.
-
公开(公告)号:AU2011234978B2
公开(公告)日:2016-03-17
申请号:AU2011234978
申请日:2011-04-01
Applicant: CYTOSORBENTS CORP
Inventor: CHAN PHILLIP P , YOUNG WEI-TAI , CAPPONI VINCENT J , GOLOBISH THOMAS D , BARLETT ROBERT H , ALI HUMAYRA BEGUM
IPC: A61K31/74
Abstract: The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.
-
公开(公告)号:AU2012204277B2
公开(公告)日:2015-11-05
申请号:AU2012204277
申请日:2012-01-06
Applicant: CYTOSORBENTS CORP
Inventor: CHAN PHILLIP P , CAPPONI VINCENT J , GOLOBISH THOMAS D , ALI HUMAYRA BEGUM
IPC: B32B5/16
Abstract: The invention concerns polymer systems comprising at least one polymer with a plurality of pores where the polymer is initially functionalized on substantially all surfaces followed by a stepwise surface specific functionalization such that a different functional group resides on the external or internal pore surface of the bead. The invention also concerns use of such polymer systems in blood, blood product, or physiologic fluid purification.
-
-
-
-
-
-
-
-
-